JasonJy

JasonJy | Joined since 2020-08-07

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

28

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
28
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2021-11-09 22:42 | Report Abuse

The point is... the company is on the verge of profitable. As long as the contract with MoH is solid and intact, it doesn't really matter alot if is import or they produce on their own. They would still be receiving their payment from MoH

Stock

2021-11-09 20:37 | Report Abuse

https://dagangnews.com/cansinos-covid-19-vaccine-ready-bigger-rollout-private-market-and-booster-shot-10436

All hope is not lost, 300,000 doses arriving by 12 Nov, 600,000 to be delivered by December
Expecting a RM300mil turnover with profit margin 15%

Roughly 45mil profit with 188mil market cap, translate PE into 4x

Stock

2020-09-25 12:14 | Report Abuse

Anyone still holding? The "sifu" all go where liao?

Stock

2020-08-27 01:11 | Report Abuse

https://www.reuters.com/article/us-health-coronavirus-cdc-moderna-idUSKBN25M1Y0

Once hwgb announce their test result, then will have similar effect like the company Moderna

Stock

2020-08-25 14:55 | Report Abuse

The Board of Directors of HWGB is pleased to announce that Astramern Nutra V Capsule (previously known as “Astramune-V”) has on 24 August 2020 been informed by the NPRA that the product registration approval has been obtained from 21 August 2020 to 21 August 2025.


https://www.klsescreener.com/v2/announcements/view/3215769

Stock

2020-08-24 22:35 | Report Abuse

How are we progressing so quickly on the coronavirus vaccine front?

One of the possible reasons is that the SARS-CoV-2 vaccine, which causes COVID-19, is from the family of coronaviruses that scientists have studied before. This meant that they could quickly adapt the vaccine projects in the works for previous coronaviruses like the SARS virus and MERS virus. The spike protein which had been pointed out earlier as a component of the coronaviruses, was identified as a target for the vaccine. “SARS-2 is quite similar to SARS-1, especially in that spike protein. People could take a very educated guess that this is the protein that we need to be going after,” Rama Rao Amara, an immunologist and vaccine researcher at Emory University told Stat News.

Stock

2020-08-18 22:24 | Report Abuse

What good news? Faster share lo!

https://www.globaltimes.cn/content/1198131.shtml

Ppl oledi got the vaccine jo and coming out by December. Howah 55 lo!!

Stock

2020-08-17 22:26 | Report Abuse

Same like Howah, hahaha vaccine gogogo!

Stock

2020-08-07 17:50 | Report Abuse

Haiyoooo all these people say cannot find the company website, of course laaaaaa. People are scientist arrr, busy doing research. A smarter person would look for the person's name laaa woii, need teach 1 mehh